DSIP (Delta Sleep-Inducing Peptide)

Delta Sleep-Inducing Peptide (DSIP) is a neuromodulating nonapeptide (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) first isolated from the cerebral venous blood of rabbits during slow-wave (delta) sleep. DSIP's mechanism centres on its modulation of sleep-regulating neuroendocrine signalling pathways in the central nervous system. Unlike many neuropeptides that act through a single identified receptor, DSIP's activity appears to be mediated through multiple pathways: it modulates GABAergic signalling (the primary inhibitory neurotransmitter system), influences serotonergic and dopaminergic pathway activity, and may interact with endogenous sleep-regulating factors in the hypothalamus and brainstem. DSIP is studied for its role in promoting slow-wave (delta) sleep — the deepest stage of non-REM sleep associated with restorative functions and growth hormone release. The peptide also modulates the hypothalamic-pituitary-adrenal (HPA) axis, influencing corticotropin-releasing hormone (CRH) and adrenocorticotropic hormone (ACTH) signalling, which connects sleep regulation to stress response pathways. Additionally, DSIP has been investigated for effects on luteinising hormone (LH) and growth hormone release, linking sleep neuroendocrinology to reproductive and metabolic research.